enGene Holdings Inc. 8-K

What Happened
enGene Holdings Inc. announced its financial results for the three months ended January 31, 2026 in a press release issued on March 9, 2026. The company furnished that press release as Exhibit 99.1 to its Form 8-K (Item 2.02), and the filing was signed by Chief Financial Officer Ryan Daws.

Key Details

• Announcement date: March 9, 2026.
• Reporting period: three months ended January 31, 2026.
• Press release furnished as Exhibit 99.1 to the Form 8-K.
• The information is furnished (not “filed”) under the Exchange Act and therefore is not subject to Section 18 liability or automatically incorporated by reference in future SEC filings.

Why It Matters
This Form 8-K notifies investors that enGene has released its latest quarterly results; the press release will contain the specific earnings, revenue, cash position and related operational details investors use to assess near‑term performance. Because the release is furnished rather than filed, investors should review Exhibit 99.1 (the press release) and any subsequent filings for full financial statements and management commentary before drawing conclusions.